XENEX
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87097077
- Registration number
- 6075207
- Mark type
- Stylized text
- Filed
- 08 Jul 2016
- Published for opposition
- 11 Jul 2017
- Registered
- 09 Jun 2020
- Attorney of record
- R. Kent Roberts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations consisting of a xenon gas for inhalation, used for neuroprotection after a neurological insult; the foregoing goods to be administered exclusively in emergency medical response (a.k.a. "EMS"), ambulance, and/or critical care hospital settings exclusively by health care professionals
Owner
- Neuroprotexeon Limited, London, GB
- Neuroprotexeon Limited, London, GB
- Neuroprotexeon Limited, London, GB
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Apr 2020 — USE AMENDMENT FILED
- 22 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 08 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Apr 2020 — SOU EXTENSION 2 GRANTED
- 06 Apr 2020 — SOU EXTENSION 2 FILED
- 06 Apr 2020 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2019 — SOU EXTENSION 1 GRANTED
- 09 Oct 2019 — SOU EXTENSION 1 FILED